Open AccessImipenem and Meropenem: Comparison of In Vitro Activity, Pharmacokinetics, Clinical Trials and Adverse Effects
Author(s) -
George G. Zhanel,
Andrew E. Simor,
Lavern M. Vercaigne,
Lionell Mandell,
the Canadian Carbapenem Discussion Group
Publication year - 1997
Publication title -
canadian journal of infectious diseases and medical microbiology
Language(s) - English
Resource type - Journals
eISSN - 1918-1493
pISSN - 1712-9532
DOI - 10.1155/1998/831425
Subject(s) - meropenem , imipenem , medicine , carbapenem , adverse effect , antibacterial agent , clinical trial , pharmacokinetics , ertapenem , antibiotics , intensive care medicine , pharmacology , microbiology and biotechnology , biology , antibiotic resistance
To compare and contrast imipenem and meropenem in terms of in vitro activity, pharmacokinetics, clinical efficacy and adverse effects.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom